Makavos, George
Κairis, Chris
Tselegkidi, Maria-Eirini
Karamitsos, Theodoros
Rigopoulos, Angelos G.
Noutsias, Michel
Ikonomidis, Ignatios
Article History
First Online: 9 March 2019
Compliance with ethical standards
:
: Michel Noutsias has received grants from the Deutsche Forschungsgemeinschaft (DFG) through the Sonderforschungsbereich Transregio 19 “Inflammatory Cardiomyopathy” (SFB TR19) (TP B2) and from the University Hospital Giessen and Marburg Foundation Grant “T cell functionality” (UKGM 10/2009). Michel Noutsias has been consultant to the IKDT (Institute for Cardiac Diagnosis and Therapy GmbH, Berlin) in 2004–2008, and has received honoraria for presentations and/or participated in advisory boards from Abiomed, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Fresenius, Miltenyi Biotech, Novartis, Pfizer, and Zoll.
: The authors declare that they have no conflicts of interest.